FOXC2-AS1
geneOn this page
Also known as ODRUL
Summary
FOXC2-AS1 (FOXC2 antisense RNA 1, HGNC:50665) is a long non-coding RNA gene on chromosome 16q24.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50665 |
| Approved symbol | FOXC2-AS1 |
| Name | FOXC2 antisense RNA 1 |
| Location | 16q24.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | ODRUL |
| Ensembl gene | ENSG00000260944 |
| Ensembl biotype | lncRNA |
| Entrez | 103752587 |
| RNAcentral | URS000050E6E3 — lncRNA, 319 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 lncRNA
ENST00000563280, ENST00000809048, ENST00000809049, ENST00000809050, ENST00000809051, ENST00000809052, ENST00000809053, ENST00000809054, ENST00000809055, ENST00000809056, ENST00000809057
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000563280 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004204455 | 86564956 | 86565318 |
| ENSE00004204463 | 86567617 | 86567929 |
Expression profiles
Bgee: expression breadth ubiquitous, 105 present calls, max score 93.05.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5532 / max 16.8180, expressed in 341 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 158447 | 0.5233 | 333 |
| 207996 | 0.0299 | 9 |
Top tissues by expression
105 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.92 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 70.48 | gold quality |
| stromal cell of endometrium | CL:0002255 | 68.72 | gold quality |
| calcaneal tendon | UBERON:0003701 | 68.16 | gold quality |
| ascending aorta | UBERON:0001496 | 67.37 | gold quality |
| thoracic aorta | UBERON:0001515 | 67.18 | gold quality |
| tibial artery | UBERON:0007610 | 67.15 | gold quality |
| popliteal artery | UBERON:0002250 | 67.03 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.27 | gold quality |
| gall bladder | UBERON:0002110 | 66.13 | gold quality |
| left coronary artery | UBERON:0001626 | 65.63 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 64.40 | gold quality |
| prefrontal cortex | UBERON:0000451 | 59.27 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 59.15 | gold quality |
| right coronary artery | UBERON:0001625 | 58.96 | gold quality |
| blood | UBERON:0000178 | 57.68 | gold quality |
| muscle of leg | UBERON:0001383 | 57.55 | gold quality |
| endometrium | UBERON:0001295 | 57.25 | gold quality |
| liver | UBERON:0002107 | 57.12 | gold quality |
| monocyte | CL:0000576 | 56.62 | gold quality |
| islet of Langerhans | UBERON:0000006 | 56.56 | gold quality |
| heart | UBERON:0000948 | 56.40 | gold quality |
| lymph node | UBERON:0000029 | 56.36 | gold quality |
| kidney | UBERON:0002113 | 56.25 | gold quality |
| heart left ventricle | UBERON:0002084 | 55.98 | gold quality |
| tibial nerve | UBERON:0001323 | 55.75 | gold quality |
| fundus of stomach | UBERON:0001160 | 55.37 | gold quality |
| right lobe of liver | UBERON:0001114 | 55.27 | gold quality |
| gastrocnemius | UBERON:0001388 | 55.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.66 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 9)
- Nrf2-mediated lncRNA ODRUL was indispensable for silver nanoparticle-induced toxicity in erythroid cells. (PMID:28351005)
- a high level of FOXC2-AS1 was associated with poor prognosis of BC patients. (PMID:29562954)
- lncRNA FOXC2-AS1 accelerated the tumor progression of prostate cancer cells by regulating the proliferation and tumor growth through miR-1253/EZH2 axis. (PMID:30389560)
- Expression level of FOXC2-AS1 in lung cancer (LCa) specimens was considerably higher than in normal tissues and correlated with higher incidence of distant metastasis and lower overall survival rate. miR-107 expression was found significantly reduced in LCa cell lines and tissues and showed a negative correlation with FOXC2-AS1. Luciferase reporter gene assay verified direct binding of FOXC2-AS1 to downstream miRNA-107. (PMID:30720176)
- LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway. (PMID:32513911)
- LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2. (PMID:32964984)
- H3K27ac-induced FOXC2-AS1 accelerates tongue squamous cell carcinoma by upregulating E2F3. (PMID:34358374)
- LncRNA ODRUL regulates progression of osteosarcoma by regulating IL-6 via sponging miR-6874-3p. (PMID:35114192)
- FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts. (PMID:37705741)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): lymphedema-distichiasis syndrome